These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Optimized clonotypic analysis of T-cell receptor repertoire in immune reconstitution. Packer AN; Muraro PA Exp Hematol; 2007 Mar; 35(3):516-21. PubMed ID: 17309832 [TBL] [Abstract][Full Text] [Related]
24. Systematic literature review and network meta-analysis in highly active relapsing-remitting multiple sclerosis and rapidly evolving severe multiple sclerosis. Huisman E; Papadimitropoulou K; Jarrett J; Bending M; Firth Z; Allen F; Adlard N BMJ Open; 2017 Mar; 7(3):e013430. PubMed ID: 28283486 [TBL] [Abstract][Full Text] [Related]
27. Dynamics of T cell repertoire renewal following autologous hematopoietic stem cell transplantation in multiple sclerosis. Ruder J; Docampo MJ; Rex J; Obahor S; Naghavian R; Müller AMS; Schanz U; Jelcic I; Martin R Sci Transl Med; 2022 Nov; 14(669):eabq1693. PubMed ID: 36322629 [TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial. Brittain G; Petrie J; Duffy KEM; Glover R; Hullock K; Papaioannou D; Roldan E; Beecher C; Bursnall M; Ciccarelli O; Coles AJ; Cooper C; Giovannoni G; Gabriel I; Kazmi M; Kyriakou C; Nicholas R; Paling D; Peniket A; Scolding N; Silber E; de Silva T; Venneri A; Walters SJ; Young C; Muraro PA; Sharrack B; Snowden JA; BMJ Open; 2024 Feb; 14(2):e083582. PubMed ID: 38316583 [TBL] [Abstract][Full Text] [Related]
29. Abundant cytomegalovirus (CMV) reactive clonotypes in the CD8(+) T cell receptor alpha repertoire following allogeneic transplantation. Link CS; Eugster A; Heidenreich F; Rücker-Braun E; Schmiedgen M; Oelschlägel U; Kühn D; Dietz S; Fuchs Y; Dahl A; Domingues AM; Klesse C; Schmitz M; Ehninger G; Bornhäuser M; Schetelig J; Bonifacio E Clin Exp Immunol; 2016 Jun; 184(3):389-402. PubMed ID: 26800118 [TBL] [Abstract][Full Text] [Related]
30. Flow cytometric analysis of TCR Vβ repertoire in patients with 22q11.2 deletion syndrome. McLean-Tooke A; Barge D; Spickett GP; Gennery AR Scand J Immunol; 2011 Jun; 73(6):577-85. PubMed ID: 21323691 [TBL] [Abstract][Full Text] [Related]
31. Low intensity lympho-ablative regimen followed by autologous hematopoietic stem cell transplantation in severe forms of multiple sclerosis: A MRI-based clinical study. Curro' D; Vuolo L; Gualandi F; Bacigalupo A; Roccatagliata L; Capello E; Uccelli A; Saccardi R; Sormani MP; Mancardi G Mult Scler; 2015 Oct; 21(11):1423-30. PubMed ID: 25583838 [TBL] [Abstract][Full Text] [Related]
32. Natalizumab affects the T-cell receptor repertoire in patients with multiple sclerosis. Warnke C; Mausberg AK; Stettner M; Dehmel T; Nekrich L; Meyer zu Horste G; Hartung HP; Fogdell-Hahn A; Adams O; Kieseier BC Neurology; 2013 Oct; 81(16):1400-8. PubMed ID: 24049136 [TBL] [Abstract][Full Text] [Related]
33. Cost and effectiveness of autologous haematopoietic stem cell transplantation and high-efficacy disease-modifying therapies in relapsing-remitting multiple sclerosis. Mariottini A; Nozzoli C; Carli I; Landi F; Gigli V; Repice AM; Ipponi A; Cecchi M; Boncompagni R; Saccardi R; Massacesi L Neurol Sci; 2024 Jul; 45(7):3379-3387. PubMed ID: 38277051 [TBL] [Abstract][Full Text] [Related]
34. Resetting the T Cell Compartment in Autoimmune Diseases With Autologous Hematopoietic Stem Cell Transplantation: An Update. Lutter L; Spierings J; van Rhijn-Brouwer FCC; van Laar JM; van Wijk F Front Immunol; 2018; 9():767. PubMed ID: 29731752 [TBL] [Abstract][Full Text] [Related]
36. NK Cells and Innate-Like T Cells After Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis. Ruder J; Rex J; Obahor S; Docampo MJ; Müller AMS; Schanz U; Jelcic I; Martin R Front Immunol; 2021; 12():794077. PubMed ID: 34975899 [TBL] [Abstract][Full Text] [Related]
37. Natalizumab for relapsing remitting multiple sclerosis. Pucci E; Giuliani G; Solari A; Simi S; Minozzi S; Di Pietrantonj C; Galea I Cochrane Database Syst Rev; 2011 Oct; (10):CD007621. PubMed ID: 21975773 [TBL] [Abstract][Full Text] [Related]
38. Deferiprone modulates in vitro responses by peripheral blood T cells from control and relapsing-remitting multiple sclerosis subjects. Sweeney ME; Slusser JG; Lynch SG; Benedict SH; Garcia SL; Rues L; LeVine SM Int Immunopharmacol; 2011 Nov; 11(11):1796-801. PubMed ID: 21807124 [TBL] [Abstract][Full Text] [Related]
39. Donor CD4 T Cell Diversity Determines Virus Reactivation in Patients After HLA-Matched Allogeneic Stem Cell Transplantation. Ritter J; Seitz V; Balzer H; Gary R; Lenze D; Moi S; Pasemann S; Seegebarth A; Wurdack M; Hennig S; Gerbitz A; Hummel M Am J Transplant; 2015 Aug; 15(8):2170-9. PubMed ID: 25873100 [TBL] [Abstract][Full Text] [Related]
40. Comprehensive assessment of T-cell repertoire following autologous hematopoietic stem cell transplantation for treatment of type 1 diabetes using high-throughput sequencing. Zhang J; Hu M; Wang B; Gao J; Wang L; Li L; Chen S; Cui B; Gu W; Wang W; Ning G Pediatr Diabetes; 2018 Nov; 19(7):1229-1237. PubMed ID: 30022578 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]